HCM
NEO icon

HMS Capital Management’s NeoGenomics NEO Stock Holding History

HMS Capital Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,847
Closed -$571K – 117
2021
Q3 		$571K Hold
11,847
– – 0.27% 70
2021
Q2 		$535K Buy
11,847
+60
+0.5% +$2.66K 0.24% 84
2021
Q1 		$567K Sell
11,787
-2,964
-20% -$154K 0.24% 70
2020
Q4 		$794K Hold
14,751
– – 0.36% 56
2020
Q3 		$544K Sell
14,751
-282
-2% -$10.5K 0.21% 89
2020
Q2 		$466K Sell
15,033
-343
-2% -$9.51K 0.2% 104
2020
Q1 		$425K Sell
15,376
-504
-3% -$15.1K 0.41% 55
2019
Q4 		$464K Hold
15,880
– – 0.2% 117
2019
Q3 		$304K Buy
+15,880
New +$372K 0.11% 165

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HMS Capital Management's NEO Position: Q4 2021 in Review

HMS Capital Management sold out of NeoGenomics (NEO) in Q4 2021, closing a stake of 11,847 shares — an estimated $571K sold.

HMS Capital Management first reported a position in NEO in Q3 2019 and held it in 9 quarters. The position peaked at $794K in Q4 2020. 307 funds tracked by Wall St. Rank hold NEO as of Q4 2021.

  • HMS Capital Management reported no remaining NeoGenomics position as of Q4 2021 after selling out during the quarter.
  • HMS Capital Management sold 11,847 NeoGenomics shares in Q4 2021, an estimated $571K.
  • HMS Capital Management first reported a position in NeoGenomics in Q3 2019 and held it in 9 quarters.
  • HMS Capital Management's NeoGenomics position peaked at $794K in Q4 2020.
  • 307 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2021.

Based on HMS Capital Management's 13F filing for Q4 2021, filed 3 Feb 2022.